Liver Disease, Liver Cancer
Conditions
Interventions
Observation group:None
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Adult patients diagnosed with liver disease or liver cancer at our center; Not participating in other clinical trials; Vital signs are stable; No cognitive impairment; The patient or family member signs an informed consent form and is able to comply with the requirements of the protocol.
Exclusion criteria
Exclusion criteria: Patients with severe diseases of important organs such as heart, lungs, kidneys, brain, and blood; Patients with severe neurological and psychiatric disorders (such as epilepsy, depression, mania, epileptic seizures, schizophrenia, etc.); Cognitive impairment; Control unstable diabetes, hypertension, thyroid disease, etc; Drug abuse or alcohol abuse; The researchers believe that the current condition of the study participants is not suitable for participating in this study; Simultaneously participate in other clinical research trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of liver disease progressing to liver cancer;Death rate during follow-up of liver disease or liver cancer;Blood Tests;Imaging examination;Cohort establishment completion rate;Pathology and staging;Modus operation;Metastasis and recurrence;Survival time; | — |
Countries
China
Contacts
Public ContactHong Wu
West China Hospital, Sichuan University
Outcome results
None listed